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Abstract: Interest in the application of cold atmospheric plasma (CAP) in the medical field has been 
increasing. Indications in dentistry are surface modifications and antimicrobial interventions. The 
antimicrobial effect of CAP is mainly attributed to the generation of reactive oxygen and reactive 
nitrogen species. The aim of this article is to systematically review the available evidence from in-
vitro studies on the antimicrobial effect of CAP on dental pathogens. A database search was per-
formed (PubMed, Embase, Scopus). Data concerning the device parameters, experimental set-ups 
and microbial cultivation were extracted. The quality of the studies was evaluated using a newly 
designed assessment tool. 55 studies were included (quality score 31–92%). The reduction factors 
varied strongly among the publications although clusters could be identified between groups of set 
pathogen, working gases, and treatment time intervals. A time-dependent increase of the antimi-
crobial effect was observed throughout the studies. CAP may be a promising alternative for antimi-
crobial treatment in a clinically feasible application time. The introduced standardized protocol is 
able to compare the outcome and quality of in-vitro studies. Further studies, including multi-species 
biofilm models, are needed to specify the application parameters of CAP before CAP should be 
tested in randomized clinical trials. 
Keywords: cold atmospheric plasma; non-thermal plasma; antimicrobial; dentistry; Streptococcus 
mutans; Enterococcus faecalis; Candida albicans; periodontal disease; peri-implant disease; in vitro 
 
1. Introduction 
The application of physical plasma in medicine is a promising tool for disinfection 
and therefore a lot of data has been published within the last decade. Developed to non-
chemically decontaminate in biomedical and food industries, cold atmospheric plasma 
(CAP) has emerged in the medical field. Plasma, often referred to as the ‘fourth state of 
matter’, is an ionized gas with approximately neutral charge. Terms such as non-thermal 
and atmospheric pressure plasma further describe the nature of the physical plasma, 
which operates under atmospheric pressure and does not exceed 50 °C and is therefore 
tolerable for human tissues. Plasma sources can be divided into indirect and direct plasma 
devices. In an indirect plasma device, commonly constructed as a jet design, plasma is 
generated by ionization of the working gas between two electrodes and constantly pushed 
out by the gas flow. In a direct plasma device—such as a plasma brush, volume dielectric 
barrier discharge (VDBD), or corona discharge device—plasma is generated between the 
electrode of the device and the treated surface, which functions as a grounded electrode. 
These devices can operate by utilizing ambient air [1]. 
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Indications of CAP application in dentistry are: bonding to dentin and ceramics, cur-
ing of composites, bleaching, surface activation of dental implants, and antimicrobial ther-
apeutic interventions in cariology, endodontology, periodontology, and implantology [2]. 
The microbicidal properties are based on the generation of reactive oxygen (ROS) and 
nitrogen species (RNS) including free radicals, charged particles, electric fields, and elec-
tric radiation such as UV radiation. Subsequently, these physical processes lead to antimi-
crobial effects, most probably caused by oxidation of cell membranes and DNA [3]. Vari-
ous structures of the microbes are targeted by ROS and RNS, the cell wall is etched, and 
the membrane is damaged by disruption and lipid peroxidation. The bacterial DNA and 
RNA are impaired by oxidative damage, base modification, and strand breaks. Further-
more macromolecules, like proteins may become unfolded or modified [3]. Most dental 
treatments are aiming to remove or disrupt the oral biofilms. An ecological shift towards 
an anaerobic environment, especially when an adequate removal of the biofilm is ham-
pered, leads to an establishment of anaerobic bacteria within the biofilm [4]. In the initial 
biofilm formation on the tooth surface, non-mutans streptococci—like Streptococcus mitis 
and Streptococcus sanguinis—are early colonizers causing acidification and introduction of 
more cariogenic microorganisms like Streptococcus mutans [5]. Lactobacilli, especially the 
subspecies L. acidophilus, L. rhamnosus, L. casei, and L. fermentum are often found in active 
carious lesions and therefore highly associated with increased caries activity [6]. Entero-
coccus faecalis is commonly known in the context of hospital acquired infections. In dentis-
try, this Gram-positive bacterium is frequently identified in reinfected root canals [7]. Por-
phyromonas gingivalis and Aggregatibacter actinomycetemcomitans are Gram-negative, anaer-
obic rods highly associated with periodontal disease [8]. P. gingivalis is capable in breaking 
down the host immunotolerance and is therefore referred to as the keystone-pathogen in 
periodontitis [9]. Some yeast strains, mainly Candida albicans, are opportunistic pathogens 
found in oral infections. Primarily known for causing denture stomatitis, C. albicans can 
also be isolated from infected root canals and periodontal or peri-implant pockets, espe-
cially in immune compromised patients. 
To the best of our knowledge, until now no systematic review has attempted to ana-
lyze the available literature on the potential antimicrobial effects of the in-vitro application 
of cold atmospheric plasma. Therefore, the aim of this systematic review was to analyze 
the available literature regarding the antimicrobial effects of in-vitro application of cold 
atmospheric plasma on various types of oral microorganisms. 
2. Methods 
2.1. Search Strategy 
The search was performed based on the PRISMA statement [10]. The following fo-
cused question was formulated: “Does the in-vitro application of cold atmospheric plasma 
show an antimicrobial effect compared to no treatment on pathogens related to dentis-
try?” According to the PICO criteria defined from the focused question (Figure 1b), a da-
tabase search was conducted in PubMed (Medline), Embase and Scopus on October 19, 
2020 by two authors separately (G.J. and D.M.). 
The results were restricted to research articles written in English. The keywords for 
the PubMed search were: (“cold atmospheric plasma” OR “non-thermal plasma” OR 
“non-thermal plasma” OR “non-thermal atmospheric plasma” OR “non thermal atmos-
pheric plasma” OR “non-thermal atmospheric pressure plasma” OR “non thermal atmos-
pheric pressure plasma” OR “cold atmospheric pressure plasma” OR “argon plasma” OR 
“helium plasma” OR “oxygen plasma” OR “nitrogen plasma” OR “air plasma” OR 
“plasma gases” OR “plasma jet” OR “dielectric barrier discharge” OR “glow discharge” 
[MeSH Terms]) AND (“dentistry” OR “dental treatment” OR “dental therapy” OR “oral”) 
AND (“disinfection” OR “sterilization” OR “bacterial inactivation” OR “bactericidal” OR 
“bacteriostatic” OR “antibacterial” OR “anti-bacterial” OR “microbicidal” OR “antimicro-
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bial” OR “anti-microbial” OR “antifungal” OR “anti-fungal” OR “antiviral” OR “anti-vi-
ral”) AND (“in-vitro” OR “in vitro”). For Scopus, the keywords were chosen in the same 
way and for Embase the PICO manager was used. References from relevant articles were 
assessed and added when appropriate. 
 
Figure 1. (a) Flow diagram of studies screened, assessed for eligibility, and included; (b) PICO 
framework, according to the PRISMA checklist [10]. 
2.2. Eligibility Criteria 
In-vitro studies investigating the direct application of plasma on pathogens associ-
ated with dental diseases were included in the analysis. Therefore, only studies focusing 
on streptococci, lactobacilli, E. faecalis, P. gingivalis, and A. actinomycetemcomitans were con-
sidered. To compare the outcome only studies specifying the reduction in log10 colony 
forming units (CFU) were included. If the reduction factor (RF) was not outlined, it was 
calculated using the formula: RF = −log10 (CFUtreatment /CFUcontrol). Results were presented 
with one decimal place. Reductions less than about 0.5 log10 were categorized as non-rel-
evant and declared as ‘no reduction’. Studies not using a control group were excluded. As 
control no treatment (no Tx), rinsing with sodium chloride (NaCl) or phosphate buffered 
saline (PBS) or working gas without plasma ignition was accepted. Furthermore, studies 
investigating the indirect plasma activity on bacteria, i.e., plasma activated water or bac-
teria in suspension were excluded. 
2.3. Data Extraction and Assessment of Quality 
The data extraction was performed by two authors (G.J. and D.M.) using a piloted 
form, which included technical parameters of the plasma device, characteristics of the 
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study setup like nozzle-specimen distance, biofilm growth duration, and RF for set treat-
ment time intervals (Table S1). In order to create a comprehensive overview, an additional 
table was made summarizing RFs for the specific working gases and treatment intervals 
(Tables 2–5). Disagreements in extracted results were resolved by discussion. To assess 
the quality of the publications, an assessment tool based on the US EPA protocol and 
standards for bactericidal activities of disinfectants [11–15] was created. The tool consists 
of 11 items, nine with one point and two with two points attainable. A maximum score of 
13 points in total could be achieved. The final score was expressed as a percentage of 
achieved points divided by maximum points multiplied by 100. The items evaluated the 
reproducibility and critical steps within the study protocol that may overestimate the out-
come. The detailed description of the assessment tool can be found in Table 1. 
2.4. Statistical Analysis 
The RFs were extracted from tables or read from graphs. The inter-rater reliability for 
the extracted RFs was calculated using the Intraclass correlation coefficient (ICC; two-way 
mixed, absolute agreement). ICC < 0.5, 0.5–0.75, 0.75–0.9, >0.9 were interpreted as poor, 
moderate, good, and excellent reliability respectively [16]. For the quality assessment the 
inter-rater reliability using Cohen’s kappa coefficient was calculated [17] with the as-
sumption of κ > 0.8/0.6/0.4/0.2/0 as almost perfect, substantial, moderate, fair or slight re-
spectively and κ < 0 as poor agreement [18]. The calculation was performed with SPSS 24 
(IBM, Armonk, NY, USA). 
3. Results 
After the duplicates were removed, 2323 articles were screened. Following exclusion 
by title and abstract, 109 articles could be assessed for eligibility (Figure 1a). Thirty-four 
studies were excluded because the authors defined another outcome than CFU, four arti-
cles did not compare the application of plasma with an untreated control, four treated 
bacteria in suspension and in five papers the effect on bacterial adhesion and de novo 
biofilm formation was analyzed. Eight articles did not investigate the antifungal effect 
related to a dental aspect. The remaining 55 publications were included in the qualitative 
synthesis (Tables 2–5). Seventeen articles investigated the antibacterial effect on plank-
tonic bacteria and 37 on bacterial biofilms. One investigated both. Sixteen studies used 
extracted teeth or a realistic resin tooth model. There, single rooted teeth were 
decoronated and the root canals were instrumented, before the roots were sterilized, in-
oculated, and incubated. The inter-rater agreement for the extracted RFs was excellent 
(ICC: 0.993). 
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Table 1. Quality assessment tool. 
Critical Steps of the in Vitro Protocol Justification Items 
Points Attributed According to the Response for 
Each Critical Step 
Preparation of micro-organisms and 
plasma device 
Scientific robustness 
1. Preparation of microorganisms 
1 if described 
0 if not described 
2. Technical data of plasma 
generator 
2 if at least 3 parameters described or commercially 
device 
1 if at least 1 parameter described 
0 if not described 
Inoculation 
(Inoculum size) 
Real inoculum size essential for the calculation of 
logarithmic reduction 
3. Experimental size presented 
2 for theoretical + true inoculum sizes 
1 for theoretical inoculum size 
0 if not described 
Test conditions Scientific robustness 
4. Experimental temperature 
1 if described 
0 if not described or over 47 °C 
5. Protection of samples 
1 if described 
0 if not described 
Micro-organisms  
recovery 
Impacts the results if not all micro-organisms are recovered, 
overestimated effect Scientific robustness 
6. Micro-organisms recovery 
1 if other method with mechanic action and 
validated with a test 
0 if not clearly described or technic not validated 
Microbial culture after treatment 
Impacts the results if the growth duration is too short  
Scientific robustness 
7. Time, temperature and method 
indicated 
1 if described 
0 if not or poorly described 
8. Culture media 
1 if described 
0 if not described 
Statistical analysis/tests repeatability Scientific robustness 
9. Number of experiments 
1 if described with more than one  
experiment 
0 if not described or described with only  
one experiment 
10. Statistical method (to compare 
differences) 
1 if described 
0 if not described 
Conflict of Interest  Bias 11. Declaration 
1 if declared 
0 if not declared 
The global score was calculated by summing each point (score = sum/13*100). 
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Table 2. Effect of CAP on bacteria associated with dental caries; Abbreviations: CD: corona discharge; conc.: concentration; DBD: dielectric barrier discharge; HA: 
hydroxyapatite; HDBD: hollow dielectric barrier discharge; max red: maximal reduction; med.: medium; pos.: positive; PTFE: polytetrafluorethylene; N/A: not 
available; nd: non-detectable; neg.: negative; ns: non-significant; self-constr.: self-constructed; Ti: titanium; VDBD: volume dielectric barrier discharge. 









Max Red t 
≤ 60 s 
Max Red t ≤ 
120 s 
Max Red t ≤ 
300 s 
Max Red t ≤ 
600 s 
Max Red t > 
600 s 
Additional 
Ar Abonti et al. 2016 [19] self-constr. jet 2 Agar No S. mutans  ns (1.4) N/A N/A N/A N/A  
  self-constr. jet 20 Agar No S. mutans  ns (1.6) N/A N/A N/A N/A  
  self-constr. jet 2 Agar No L. fermentum  ns (1.1) N/A N/A N/A N/A  
  self-constr. jet 20 Agar No L. fermentum  ns (0.7) N/A N/A N/A N/A  







Yes S. mitis  ns (0.2) N/A N/A N/A N/A  
 Blumhagen et al. 2014 
[21] 
self-constr. brush 5 HA discs No L. acidophilus 1.7 N/A N/A N/A N/A high conc. 
  self-constr. brush 5 HA discs No L. acidophilus nd N/A N/A N/A N/A 
med. conc., nd after 
13 s 
  self-constr. brush 5 HA discs No L. acidophilus nd N/A N/A N/A N/A 
low conc., nd after 10 
s 
  self-constr. brush 5 HA discs No L. acidophilus  nd N/A N/A N/A N/A nd after 13 s 
  self-constr. brush 5 HA discs No L. acidophilus  nd N/A N/A N/A N/A nd after 13 s 
  self-constr. brush 5 HA discs No L. acidophilus  nd N/A N/A N/A N/A nd after 13 s 
  self-constr. brush 5 HA discs No S. mutans 2.6 N/A N/A N/A N/A high conc. 
  self-constr. brush 5 HA discs No S. mutans nd N/A N/A N/A N/A 
med. conc., nd after 
13 s 
  self-constr. brush 5 HA discs No S. mutans nd N/A N/A N/A N/A low conc., nd after 6 s 
  self-constr. brush 5 HA discs No S. mutans  nd N/A N/A N/A N/A nd after 13 s 
  self-constr. brush 5 HA discs No S. mutans  nd N/A N/A N/A N/A nd after 13 s 
  self-constr. brush 5 HA discs No S. mutans  nd N/A N/A N/A N/A nd after 17 s 
 Gorynia et al. 2013 [22] kinpen 09 jet 10 Ti discs Yes S. sanguinis ns (0.1) ns (0.3)  nd (0.5) N/A N/A  
 Hertel et al. 2018 [23] 
kINPen 
med 
jet 8 Dentin Yes L. rhamnosus 1.1 N/A N/A N/A N/A  
  PlasmaDer
m  
VDBD close contact Dentin Yes L. rhamnosus  0.6 N/A N/A N/A N/A  
 Huang et al. 2013 [24] self-constr. jet 3 Glass No S. mutans  2.7 3.1 nd  N/A N/A  
  self-constr. jet 3 Glass No S. mutans  1.5 2.5 4.8 N/A N/A  
 Koban et al. 2011 [25] kINPen 09 jet 7 Ti discs Yes S. mutans  3.1 2.8 3 3 N/A  
   HDBD 5 Ti discs Yes S. mutans  1 1.2 1.7 1.7 N/A  
   VDBD 15 Ti discs Yes S. mutans  2 3.3 5.1 5.8 N/A  
 Park et al. 2014 [26] self-constr. jet 8 Glass No S. mutans  3 3.8 5.3 N/A N/A  
  self-constr. jet 8 Tooth No S. mutans  3 3 3.4 N/A N/A  
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jet 8 Ti implants Yes S. mitis 2.2 1.9 N/A N/A N/A  
 Yang et al. 2011 [28] self-constr. brush  Filter paper Yes S. mutans  nd N/A N/A N/A N/A nd after 11 s 
  self-constr. brush  Filter paper Yes S. mutans  nd N/A N/A N/A N/A nd after 9 s 
  self-constr. brush  Filter paper Yes S. mutans  nd N/A N/A N/A N/A nd after 15 s 
  self-constr. brush  Glass slide Yes S. mutans  nd N/A N/A N/A N/A nd after 15 s 
  self-constr. brush  PTFE Yes S. mutans  nd N/A N/A N/A N/A nd after 13 s 
  self-constr. brush  PTFE Yes S. mutans  nd N/A N/A N/A N/A 
10% density, nd after 
5 s 
  self-constr. brush  PTFE Yes S. mutans  nd N/A N/A N/A N/A 
1% density, nd after 3 
s 
  self-constr. brush  Filter paper Yes L. acidophilus 2.2 3.9 nd N/A N/A  
  self-constr. brush  Filter paper Yes L. acidophilus 3.7 4.3 nd N/A N/A nd after 210 s 
  self-constr. brush  Filter paper Yes L. acidophilus 1.9 3.2 nd N/A N/A nd after 300 s 
  self-constr. brush  Glass slide Yes L. acidophilus 1.4 2.4 nd  N/A N/A  
  self-constr. brush  PTFE Yes L. acidophilus 2 3 nd N/A N/A  
  self-constr. brush  PTFE Yes L. acidophilus  3.9 nd N/A N/A N/A 
10% density, nd after 
90 s 
  self-constr. brush  PTFE Yes L. acidophilus   nd N/A N/A N/A N/A 1% density 
Ar + O2 
Blumhagen et al. 2014 
[21] 
self-constr. brush 5 HA discs Yes L. acidophilus nd N/A N/A N/A N/A 
Ar/O2: 60:1, nd after 
13 s 
  self-constr. brush 5 HA discs Yes L. acidophilus nd N/A N/A N/A N/A 
Ar/O2: 6:1, nd after 13 
s 
  self-constr. brush 5 HA discs Yes L. acidophilus nd N/A N/A N/A N/A 
Ar/O2: 1:2, nd after 13 
s 
  self-constr. brush 5 HA discs Yes S. mutans nd N/A N/A N/A N/A 
Ar/O2: 300:5, nd after 
13 s 
  self-constr. brush 5 HA discs Yes S. mutans nd N/A N/A N/A N/A 
Ar/O2: 6:1, nd after 13 
s 
  self-constr. brush 5 HA discs Yes S. mutans nd N/A N/A N/A N/A 
Ar/O2: 1:2, nd after 17 
s 
 Hong et al. 2019 [29] self-constr. brush  Steel wafers Yes S. mutans 0.3 0.5 N/A N/A N/A Ar/O2: 100:1 
 Koban et al. 2011 [25] kINPen 09 jet 7 Ti discs Yes Saliva ns (0.3) ns (0.5) ns (0.4) N/A ns (0.7) Ar/O2: 100:1 
  kINPen 09 jet 7 Ti discs Yes S. mutans 2 1.9 2.1 N/A 1.8 Ar/O2: 100:1 
   HDBD 5 Ti discs Yes Saliva ns (0.5) 1.4 3.1 N/A 2.2 Ar/O2: 100:1 
   HDBD 5 Ti discs Yes S. mutans ns (0) 0.9 3 N/A 3.7 Ar/O2: 100:1 
Air Hertel et al. 2018 [23] 
PlasmaDer
m 
VDBD 0 Dentin Yes L. rhamnosus 0.6 N/A N/A N/A N/A  
 Kovalova et al. 2014 
[30] 
self-constr. pos. CD 5 Teeth Yes Streptococci N/A 0.9 1 2.6 N/A  
  self-constr. neg. CD 5 Teeth Yes Streptococci  N/A 0.8 1.3 2.4 N/A  
Antibiotics 2021, 10, 211 8 of 26 
 
 
 Liguori et al. 2017 [31] self-constr. DBD-Rod 3 Well Plate No S. mutans 2.1 2.9 N/A N/A N/A  
  self-constr. DBD-Plate 3 Well Plate No S. mutans 1.8 2.8 N/A N/A N/A  
  self-constr. DBD-Rod 3 Well Plate Yes S. mutans 0.8 1.8 N/A N/A N/A  
  self-constr. DBD-Plate 3 Well Plate Yes S. mutans 0.6 1.6 N/A N/A N/A  
He Molnar et al. 2013 [32] self-constr. DBD 2 Tooth Slices Yes S. mutans  1.3 nd N/A N/A N/A high conc. 
  self-constr. DBD 2 Tooth Slices Yes S. mutans  2.4 nd N/A N/A N/A med. conc. 
  self-constr. DBD 2 Tooth Slices Yes S. mutans  2.3 nd N/A N/A N/A low conc. 
He + O2 
+ N2 
Rupf et al. 2010 [33] self-constr. jet 1.5 Agar Yes S. mutans 5.8 8.4 N/A N/A N/A He/O2/N2: 2:1.2:1.5 
  self-constr. jet 1.5 Dentin slice No S. mutans 4 N/A N/A N/A N/A He/O2/N2: 2:1.2:1.5 
  self-constr. jet 1.5 Agar Yes L. casei nd nd N/A N/A N/A He/O2/N2: 2:1.2:1.5 
  self-constr. jet 1.5 Dentin slice No L. casei 4.5 N/A N/A N/A N/A He/O2/N2: 2:1.2:1.5 
N2 Abonti et al. 2016 [19] self-constr. jet 2 Agar No S. mutans 6.2 N/A N/A N/A N/A  
  self-constr. jet 20 Agar No S. mutans 7 N/A N/A N/A N/A  
  self-constr. jet 2 Agar No L. fermentum  1.8 N/A N/A N/A N/A  
  self-constr. jet 20 Agar No L. fermentum  2.3 N/A N/A N/A N/A  
 Yoo et al. 2020 [34] self-constr. jet  HA discs Yes S. mutans 0.6 1 N/A N/A N/A  
O2 Abonti et al. 2016 [19] self-constr. jet 2 Agar No S. mutans nd  N/A N/A N/A N/A  
  self-constr. jet 20 Agar No S. mutans nd  N/A N/A N/A N/A  
  self-constr. jet 2 Agar No L. fermentum  2.4 N/A N/A N/A N/A  
  self-constr. jet 20 Agar No L. fermentum  nd N/A N/A N/A N/A  
O2 + N2 Abonti et al. 2016 [19] self-constr. jet 2 Agar No S. mutans 5.2 N/A N/A N/A N/A  
  self-constr. jet 20 Agar No S. mutans 6.8 N/A N/A N/A N/A  
  self-constr. jet 2 Agar No L. fermentum  ns (1.7) N/A N/A N/A N/A  
  self-constr. jet 20 Agar No L. fermentum  2.3 N/A N/A N/A N/A  
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Table 3. Effect of CAP on E. faecalis; Abbreviations: conc.: concentration; DBD: dielectric barrier discharge; HA: hydroxyapatite; H2O2: hydroxy peroxide; max red: 
maximal reduction; N/A: not available; NaOCl: sodium hypochlorite; nd: non-detectable; ns: non-significant; self-constr.: self-constructed. 










Max Red t ≤ 
60 s 
Max Red t ≤ 
120 s 
Max Red t ≤ 
300 s 
Max Red t ≤ 
600 s 














0.5 N/A N/A N/A N/A  










N/A N/A N/A 1.5 1.8  










3.2 N/A N/A N/A N/A  
Ar + 
O2 










N/A N/A N/A 0.5 1.9 Ar/O2: 100:1  










N/A 6.6 N/A N/A N/A Ar/O2: 1000:1 









N/A N/A 2.3 6.3 nd Ar/O2: 98:2 









N/A 0.6 1.2 nd N/A Ar/O2: 98:2 










N/A 0.2 0.8 2 N/A Ar/O2 
He 














































nd nd  nd  N/A N/A 32 W 









4 nd nd  N/A N/A  










N/A N/A 1 2.1 N/A  










0.2 N/A 4 N/A N/A  















N/A N/A 1.2 N/A N/A He/O2: 100:1 

































2.9 3 3.7 N/A N/A He + 10% O2 










N/A N/A 1.4 5.1 N/A He/O2: 200:1 









N/A N/A 0.9 2.8 3.2 He/O2: 100:1 










N/A N/A N/A N/A 1 He/O2: 99:1 









N/A N/A N/A N/A 2 He/O2: 80:20 





































N/A N/A 3.4 N/A N/A He/O2: 96:4 



















N/A N/A 2.2 2.4 5.4 
He/O2: 100:1, He through 
NaOCl 










4.9 6.1 7 N/A N/A He through H2O2 









N/A N/A N/A 2 N/A  




DBD  Glass  
E. 
faecalis 
N/A 4 4.5 5.2 5.4  
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SMD 10 Agar Yes 
E. 
faecalis 



























1.7 N/A 2.4 4.9 N/A  










0.1 N/A N/A N/A N/A  
Air + 
O2 









2.9 3.1 3.6 N/A N/A air through H2O2 
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Table 4. Effect of CAP on bacteria associated with periodontal disease; Abbreviations: conc.: concentration; DBD: dielectric barrier discharge; max red: maximal 
reduction; N/A: not available; nd: non-detectable; ns: non-significant; self-constr.: self-constructed; Ti: titanium. 









Max Red t ≤ 
60 s 
Max Red t ≤ 
120 s 
Max Red t ≤ 
300 s 
Max Red t ≤ 
600 s 
Max Red t > 
600 s 
Ar Abonti et al. 2016 [19] self-constr. jet 2 Agar No A. actinomycetemcomitans ns (0.2) N/A N/A N/A N/A 
  self-constr. jet 20 Agar No A. actinomycetemcomitans ns (0.3) N/A N/A N/A N/A 
 Annunziata et al. 2016 
[56] 
Plasma R DBD  Ti discs Yes A. actinomycetemcomitans N/A N/A N/A N/A nd 
 Carreiro et al. 2019 [57] 
kINPen 
med 
jet 7 Ti discs Yes P. gingivalis 1.2 N/A 1.2 N/A N/A 
Air Liguori et al. 2017 [31] self-constr. DBD-Rod 3 
Well 
Plate 
No A. actinomycetemcomitans 2.2 2.8 N/A N/A N/A 
  self-constr. DBD-Plate 3 
Well 
Plate 
No A. actinomycetemcomitans 1.7 2.8 N/A N/A N/A 
  self-constr. DBD-Rod 3 
Well 
Plate 
Yes A. actinomycetemcomitans 1 1.8 N/A N/A N/A 
  self-constr. DBD-Plate 3 
Well 
Plate 
Yes A. actinomycetemcomitans 1.1 2 N/A N/A N/A 
 Yang et al. 2018 [58] self-constr. jet 15 Agar  P. gingivalis N/A 4 4.5 nd  N/A 
He Lee et al. 2019 [59] self-constr. jet 30 Ti discs Yes P. gingivalis N/A N/A 1.2 nd  N/A 
O2 Abonti et al. 2016 [19] self-constr. jet 2 Agar No A. actinomycetemcomitans 1.9 N/A N/A N/A N/A 
  self-constr. jet 20 Agar No A. actinomycetemcomitans nd  N/A N/A N/A N/A 
N2 Abonti et al. 2016 [19] self-constr. jet 2 Agar No A. actinomycetemcomitans ns (0.4) N/A N/A N/A N/A 




Abonti et al. 2016 [19] self-constr. jet 2 Agar No A. actinomycetemcomitans 1.2 N/A N/A N/A N/A 
  self-constr. jet 20 Agar No A. actinomycetemcomitans 1.2 N/A N/A N/A N/A 
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Table 5. Effect of CAP on C. albicans; Abbreviations: DBD: dielectric barrier discharge; HDBD: hollow dielectric barrier discharge; max red: maximal reduction; 
PMMA: polymethylmethacrylate; N/A: not available; nd: non-detectable; ns: non-significant; self-constr.: self-constructed; Ti: titanium; VDBD: volume dielectric 
barrier discharge. 









Max Red t ≤ 
60 s 
Max Red t ≤ 
120 s 
Max Red t ≤ 
300 s 
Max Red t ≤ 
600 s 
Max Red t > 
600 s 
Additional 
Ar Handorf et al. 2018 [60] 
kINPen 
09 
jet 18 Well-plate Yes 
C. 
albicans 
1 1.5 2 N/A N/A  
 Koban et al. 2010 [40] 
kINPen 
09 
jet 7 Ti Yes 
C. 
albicans 
0.4 0.5 0.5 0.3 N/A  
  self-
constr. 
HDBD 7 Ti Yes 
C. 
albicans 
1.7 1.4 2 2.9 N/A  
  self-
constr. 
VDBD 15 Ti Yes 
C. 
albicans 
2.3 2.2 3.5 5.2 N/A  
 Matthes et al. 2015 [61] 
self-
constr. 
VDBD  PMMA Yes 
C. 
albicans 
1.2 N/A 2.8 4.1 N/A  
  self-
constr. 
VDBD  PMMA Yes 
C. 
albicans 
N/A N/A N/A ns (0.1) N/A  
  self-
constr. 
VDBD  PMMA Yes 
C. 
albicans 
N/A N/A N/A ns (−0.26) N/A  






1.7 N/A N/A N/A N/A  
 Doria et al. 2019 [63] 
self-
constr. 















N/A N/A N/A N/A 1.5 continous 




jet 10 Agar  
C. 
albicans 
N/A N/A ns (0.1) 0.4 0.5  








































N/A N/A N/A N/A 1.6 Ar/Air: 6:4, pulsed 
Ar + O2 Kerlikowski et al. 2020 [65] 
kINPen 
08 
jet 1–2 Root canals Yes 
C. 
albicans 
N/A N/A N/A 2.1 2.7 Ar/O2: 100:1 
 Koban et al. 2010 [40] 
kINPen 
09 
jet 7 Ti Yes 
C. 
albicans 
0.6 1 0.8 0.5 N/A Ar/O2: 100:1 





HDBD  Ti Yes 
C. 
albicans 
1.4 1.4 3 3.3 N/A Ar/O2: 100:1 
 Matthes et al. 2015 [61] 
self-
constr. 
VDBD  PMMA Yes 
C. 
albicans 
ns (0.6) N/A 0.6 0.9 N/A Ar/O2: 100:1 
 Wang et al. 2016 [66] 
self-
constr. 
jet  10 PMMA Yes 
C. 
albicans 
1.9 2.6 3 5.9 N/A Ar/O2: 98:2 
Air Maisch et al. 2012 [67] 
self-
constr. 
SMD 6 Well-plate No 
C. 
albicans 
5.5 nd nd nd N/A  
  self-
constr. 
SMD 6 Well-plate Yes 
C. 
albicans 
0.1 0.7 0.6 nd  N/A  
 Yoo et al. 2016 [68] 
self-
constr. 
jet 3 PMMA No 
C. 
albicans 
N/A 1.3 N/A N/A N/A  
He Chiodi et al. 2017 [69] 
self-
constr. 
jet 15 Well-plate Yes 
C. 
albicans 
ns (0.3) N/A 1.5 1.7 N/A  
 Song et al. 2012 [70] 
self-
constr. 
brush  Glass Yes 
C. 
albicans 
0.5 0.9 1 N/A N/A  









N/A N/A N/A N/A 1.1 continous  
  self-
constr. 






N/A N/A N/A N/A 1.2 pulsed 








































N/A N/A N/A N/A 1 He/Air: 1:9, pulsed 
He + O2 He et al. 2020 [71] 
self-
constr. 
jet 10 Well-plate Yes 
C. 
albicans 
N/A 0.2 0.4 0.8 N/A He/O2: 99.5:0.5 
 Song et al. 2012 [70] 
self-
constr. 
brush  Glass Yes 
C. 
albicans 
0.4 0.8 1 N/A N/A He + O2 1% 
  self-
constr. 
brush  Glass Yes 
C. 
albicans 
0.8 1.2 1.5 N/A N/A He + O2 5% 
  self-
constr. 
brush  Glass Yes 
C. 
albicans 
0.5 1 1 N/A N/A He + O2 7% 
 Sun et al. 2012 [72] 
self-
constr. 
  Well-plate Yes 
C. 
albicans 
nd N/A N/A N/A N/A He/O2: 98:2 
  self-
constr. 
  Well-plate Yes 
C. 
albicans 
nd N/A N/A N/A N/A He/O2: 98:2 





  Well-plate Yes C. krusei nd N/A N/A N/A N/A He/O2: 98:2 
  self-
constr. 
  Well-plate Yes C. krusei nd N/A N/A N/A N/A He/O2: 98:2 
He + O2 + 
N2 
Rupf et al. 2010 [33] 
self-
constr. 
jet 1.5 Agar Yes 
C. 
albicans 
5 N/A N/A N/A N/A He/O2/N2: 2:1.2:1.5 
N2 Yoo et al. 2016 [68] 
self-
constr. 
jet 3 PMMA No 
C. 
albicans 
N/A 1 N/A N/A N/A  
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3.1. Oral Streptococci 
In total, 15 studies exposed streptococci biofilms to plasma, utilizing either different 
noble gases or ambient air to apply the plasma to the microbes (Table 2). More than half 
of the studies used an argon plasma device. In the shortest treatment interval of up to 60 
s, some groups demonstrated bacterial elimination below the detection level [21,28], 
whereas others found no significant reduction [19,20,22,25]. For the other time intervals, 
the RF ranged from no reduction [22] to 3.8 log10 CFU [26] within 120 s and from no re-
duction [22,25] to complete elimination of CFU [24] in 300 s, respectively. Koban et al. 
applied argon plasma for up to 600 s resulting in a decrease from 1.7 log10 CFU for a hollow 
DBD device to 5.8 log10 CFU reduction for a volume DBD [25]. Blumhagen et al. found 
complete sterilization in 60 s [21]. Molnar et al. used a helium plasma device for 60 and 
120 s, respectively. 60 s resulted in a range of 1.3–2.3 log10 CFU reduction, 120 s of treat-
ment led to reduction below detection level [32]. For nitrogen plasma, studies with up to 
60 and 120 s respectively were performed. In 60 s, values ranged between 0.6 [34] and 1.5 
[19], 120 s resulted in 1 log10 CFU reduction [34]. Two groups of authors tested DBD 
plasma devices, utilizing ambient air. RF values for 60 s ranged from 0.6–1.2 log10 [31], and 
for up to 600 s from 2.4–2.6 log10 CFU [30]. Rupf et al., who used a combination of helium, 
nitrous oxide, and oxygen, achieved higher RF values, ranging from 4.0 to 5.8 log10 CFU 
reduction in comparable treatment times [33]. 
3.2. Lactobacilli 
In five studies, lactobacilli were treated with different plasma devices (Table 2). Most 
authors focused on short treatment times of 60 s with devices that used argon as a working 
gas. In this category, one group of authors found no reduction [19], two others a decrease 
of CFU below detection level [21,33]. The other two studies demonstrated a consistent but 
relatively low reduction rate of about 1.0–1.5 log10 units. Rupf et al. showed reduction 
values of 4.5 log10 and more using a mixture of helium, nitrous oxide and oxygen [33]. 
Treating for up to 60 s with nitrous oxide resulted in 0.6–1 log10 CFU reduction, pure ox-
ygen rendered values from 1.3 log10 to complete sterilization and a combination of both 
gases showed no reduction up to 0.9 log10 CFU [19]. 
3.3. Enterococcus faecalis 
In total, 22 studies exposed E. faecalis to plasma (Table 3). For the plain model exper-
iments, the carrier gas was either argon or helium, in three studies an admixture of oxygen 
added to helium was used. Except for the He/O2 plasma, the studies demonstrated a 
higher RF when the treatment time was longer. The reduction values for devices utilizing 
ambient air in all time intervals were demonstrated by two of the studies. The application 
of 60 s led to results ranging from no reduction to 7.9 log10 reduction units [55]. For pure 
helium plasma, outcomes ranged from no reduction [45] to no detection of CFU within 60 
s [42]. When admixing O2, values ranged from 2.9 log10 for 10% O2, and elimination of all 
CFU for 2.5% O2 in up to 60 s treatment [43]. 
Six groups of authors utilized argon or Ar/O2 plasma, eight helium or He/O2 plasma 
on E. faecalis cultures inoculated in root canals of extracted teeth. In one study an air-
driven jet was used additionally [52]. Ballout et al. used a DBD device and showed no 
significant reduction after an application time of 60 s [35]. Concerning plasma devices 
operating with pure argon, the reduction ranged from no reduction [35] to 3.2 log10 units 
[37] for treatment up to 60 s. A treatment time over 10 minutes led to a reduction of 1.8 
log10 CFU in minimum [36] and to a non-detectable number in maximum [39]. For devices 
operating with argon plus an admixture of oxygen, values ranged from no reduction to 
6.6 log10 CFU for up to 120 s [38,40] Eight studies utilizing helium or helium plus admix-
tures were included. For pure helium, no reduction in the time less or equal 60 s was 
shown [45]. In the same study, the reduction in the group up to 300 s was 4.0 log10 [45], 
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whereas another group observed no reduction [44]. Higher RFs were achieved when ad-
mixing O2 to helium. For the interval up to 300 s the reduction ranged from 2.8 [47] to 5.1 
log10 CFU [44]. A Chinese group investigated different admixtures to helium and He/O2 
gas. They let the working gas flow through hydrogen peroxide (H2O2) [52] and sodium 
hypochloride (NaOCl) [51] before the plasma was ignited. The values of the RF were: 4.9 
log10 (He plus H2O2) in up to 60 s, 7.0 log10 (He plus H2O2) and 2.2 log10 (He/O2 plus NaOCl) 
in up to 300 s, 2.4 log10 (He/O2 plus NaOCl) in up to 600 s and 5.4 log10 CFU for a treatment 
time over 600 s. 
3.4. Periopathogens 
Three studies report on the activity of plasma on P. gingivalis (Table 4). For P. gingi-
valis, the maximum reduction in the time interval up to 60 s was 1.2 log10 CFU for argon 
[57]. Up to 120 s air plasma reached 4.0 log10 CFU [58]. In the group up to 300 s a RF of 1.2 
log10 CFU was achieved for argon [57] and helium plasma [59]. In the same interval, the 
air driven device obtained a reduction of 4.5 log10 CFU [58]. 
Three studies investigated the effect of CAP on A. actinomycetemcomitans (Table 4). 
Direct application of argon plasma showed a non-significant reduction compared to the 
control group at a treatment time of less than 1 minute [19], but the numbers of CFU de-
creased to a non-detectable level after more than 10 minutes [56]. When using different 
working gases, the values of RF increased. For oxygen plasma, a reduction of 1.9 log10 CFU 
and a reduction below the detection level was shown for up to 60 s at treatment distances 
of 20 and 2 mm, respectively [19]. Using a DBD values for less than 1 min treatment time 
range from 1.1 to 2.2 log10 and for 2 min from 1.8 to 2.8 log10 CFU reduction [31]. Consist-
ently, a time-dependent increase of the bacterial inactivation was evident among the stud-
ies. 
3.5. Candida 
Fourteen studies investigated the antifungal properties of CAP on C. albicans and 
Candida krusei (Table 5). Using pure Ar plasma, the RF ranged from no reduction for a jet 
device to 2.3 log10 CFU for volume DBD within a treatment time up to 60 s, and from 0.5 
for jet and 2.2 log10 up to 120 s [73]. For the time interval up to 300 s, the reductions were 
between no deactivation [64] and 3.5 log10 CFU [73]. Highly matured biofilm, grown for 7 
and 16 days, showed no reduction after a treatment time of up to 600 s [61], whereas the 
values for 24–48 hours biofilm ranged from no reduction to 5.2 log10 CFU dependent on 
the device type [73]. Admixing O2 to Ar the attained reduction was very similar compared 
to pure Ar. Kerlikowski et al. used an Ar/O2 jet device to treat C. albicans in root canals. 
The reduction achieved was 2.1 CFU in less than 600 s [65]. He/O2 resulted in total inacti-
vation of a C. albicans and a C. krusei biofilm within 60 s [72], whereas another group of 
authors showed a reduction of 0.4 to 0.8 log10 CFU dependent on the amount of oxygen 
admixed [70]. Using an air-based device, Maisch et al. attained a reduction of 5.5 log10 in 
60 s and a total elimination in all longer application intervals when treating planktonic C. 
albicans. For a 24-hours biofilm, the RF was 0.7 log10 after 120 s of treatment. 
3.6. Multi-Species Biofilm 
Two studies were performed investigating the effect on an ex-vivo, multi-species bio-
film. The first one was published by Koban et al. analyzing the inactivation ability of dif-
ferent devices and oxygen admixtures on an aerobically cultured saliva biofilm. The re-
duction values for a pure argon jet were 1.6, 1.8, 1.5, and 1.4 log10 for treatment intervals 
of up to 60, 120, 300, and 600 s, respectively. When adding oxygen, no reduction was found 
at any time interval. For a hollow DBD device values were 1.2, 1.6, 1.4, and 1.5 log10. An 
oxygen admixture resulted in no reduction for 60 s, and 1.4, 3.1, 2.2 log10 for 120, 300, and 
600 s. The highest reduction was obtained using a volume DBD device showing 3.9, 3.7, 
5.3, and 5.6 log10 reduction in up to 60, 120, 300, and 600 s treatment, respectively [25]. 
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Secondly, one study was conducted treating an ex-vivo biofilm in a root canal. The ob-
tained reduction was 1.0 log10 CFU for an application time of 30 min in total [48]. 
3.7. Quality Assessment 
The scores in the quality assessment ranged from 38% to 92% while 54% (11/55 pub-
lications), 62% (10/55 publications), and 77% (10/55 publications) were achieved most fre-
quently (Table S2). Eight articles were rated under 50%. The inter-rater agreement was 
almost perfect (κ = 0.825). A point in item 5 was assigned when measures are described to 
protect specimens in surrounding wells, when not actively treated, to avoid cumulative 
effects caused by generated ozone and dehydration, for example. In two out of 55, a point 
for item 5 was obtained [60,69]. 
4. Discussion 
This systematic review intended to give an overview of the current in-vitro data con-
cerning the antimicrobial effect of CAP on pathogens associated with dental diseases. Fur-
thermore, factors which should be considered for further in-vitro studies and for future 
clinical applications were defined. Due to the high heterogeneity of the study designs—
e.g., device parameters like power, frequency, working gas composition, application time, 
nozzle-specimen distance, underlying surface, and biofilm growth duration, that influ-
ence the outcome—a quantitative synthesis was not considered to be beneficial. In the 
majority of the studies, a reduction of 3 or more log10 units in vitro, which is considered 
to be bactericidal [74], was achieved within a treatment time of 2 minutes. The antibacte-
rial activity increased in a time-dependent manner. This suggests that the application of 
CAP may represent a promising alternative or an adjunctive in antibacterial therapy. 
Thirteen studies were conducted using a commercially available device. In 12 studies 
kINPen (neoplas med, Greifswald, Germany) was used, and in two of these 12 studies 
additionally PlasmaDerm (CYNOGY System, Duderstadt, Germany). One study tested 
Plasma R (Sweden & Martina, Due Carrare, Italy). Forty-two groups of authors tested self-
constructed devices. Various device parameters influenced the outcome and should there-
fore be taken into account in terms of reproducibility. An increase in power [28,42] en-
hanced the bacterial inactivation, but also results in an increase of plasma temperature 
[42]. Additionally, the gas flow influences the plasma temperature [75]. To avoid thermal 
damage of the treated tissues the device parameters need to be adjusted [76]. Some devices 
used in the included studies are not designed for a chairside usage, e.g., plasma was gen-
erated in a locked box filled with noble gas [56,67]. These studies rather proved the prin-
ciple. For an implementation in clinical practice, the devices need to be designed as a 
hand-held device and a plasma generation with ambient air is favorable over pressurized 
gas cylinders. 
The question, whether adding oxygen to a noble gas plasma device results in better 
RF values, remains unclear based on the included studies. This may be due to the fact that 
different types of devices were used and the advantageous effect of O2 admixture depends 
on the mode of plasma generation [25]. When adding oxygen near the grounded electrode 
of a DBD device, the reduction of CFU did not differ compared to pure argon [21]. For a 
DBD brush device, Chen et al. showed that adding 1.0 to 2.5% of oxygen to helium plasma 
was favorable in reducing E. faecalis biofilms. The admixture of 5% oxygen to helium also 
showed an increased antifungal effect on a C. albicans biofilm [70]. The antimicrobial prop-
erties of CAP are attributed to the generation of ROS, RNS, electrons, and UV radiation, 
whereas ROS is supposed to play the main part [3,77]. In the electric field between the two 
electrodes of the plasma device, the atoms of the noble gases are ionized, and electrons 
are released. These electrons react with oxygen and nitrogen and form radicals. In terms 
of a brush device, adding oxygen up to 2.5–5% of volume prior to the working gas ioniza-
tion results in an increased microbicidal inactivation due to an elevated ROS generation. 
However, using higher percentages of oxygen had a contrary effect [43,70]. Song et al. 
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explained that by a higher density of reactive species which results in augmented colli-
sions with free electrons within the electric field and a lesser number of radicals in the 
effluent [70]. 
Admixture of hydrogen peroxide 3% to helium also enhances the bacterial deactiva-
tion by enhancing ROS production as analyzed in the optical emission spectrum [52]. 
The values of RF varied markedly among the studies although a cluster within the 
ranges could be seen. Various devices were used which affect the outcome as described 
earlier. However, differences in specimen preparation, biofilm growth duration and bac-
terial characteristics also affected the results. To evaluate the possible indication of CAP 
application in the various fields of dentistry bacteria were grown on different surfaces like 
dentine or hydroxyapatite for cariogenic, titanium for peri-implant biofilms, or porcine 
bone for osteitis. Some studies simply used laboratory consumables like well-plates, agar 
in Petri dishes, cover glasses, or filter paper. Taken together the findings of the plain sur-
face experiments, a bigger roughness of porous surfaces offers a cover to evade the plasma 
assault [20,26,33]. The achieved reduction in log10 CFU was also dependent on the inocu-
lum size. Lower concentrations of S. mutans and L. acidophilus resulted in an increased 
inactivation [21,28,32]. In general, biofilm maturation was associated with an augmented 
resistance to CAP application in Gram-positive [22,24,31,55] and Gram-negative species 
[31]. The maturation of the biofilm is accompanied with the production of an extracellular 
matrix and an increase of biofilm thickness. Therefore, the deeper cell layers are better 
protected and need an extended treatment time for inactivation [24]. Fifteen studies were 
performed using a single-species S. mutans biofilm. This Gram-positive coccus is the most 
relevant pathogen in the establishment of carious lesions and therefore commonly used 
to investigate dental biofilms, but it is also recently advancing to a model organism for 
biofilm in microbiology due to its facilitated handling [78]. In terms of a caries preventive 
therapy, Sprague-Dawley rats were treated with CAP for 2 min on the molars of one side, 
the other side served as control. After six months the caries rate on the test side was de-
creased by 20% compared to the control [29]. Another possible clinical application could 
be the disinfection of the cavity after caries excavation. CAP eliminates remaining patho-
gens and alters the tooth surface. CAP treatment showed an increase in bonding strength 
in the dentin–adhesive interface [79–81] and enhanced enamel remineralization [82,83]. 
This may prevent secondary caries. 
In an inhospitable environment like the oral cavity, microorganisms were forced to 
develop surviving strategies. Therefore, they organize themselves in a symbiotic commu-
nity supporting each other [5]. Multi-species biofilms are less susceptible to chemical an-
timicrobial agents, antibiotics [84], and to CAP [85]. In the study of Koban et al., the RF 
for S. mutans biofilm was 3.1, whereas the RF for an ex-vivo, saliva biofilm was 1.6 log10 
CFU using an argon plasma jet for 60 s [25]. Another aspect of the latter publication should 
be taken into account when interpreting the results. The S. mutans and the saliva biofilms 
were incubated aerobically. The authors stated that this may result in a selection of more 
aerotolerant species within the saliva biofilm and a suppression of Gram-negative anaer-
obic species, which are more susceptible to ROS [25]. Therefore, the lower antibacterial 
effect can be caused by the multi-species biofilm or by the pre-treatment selection due to 
the aerobic incubation. Furthermore, the altered biofilm composition may not represent 
the clinical reality. 
Six studies elucidated the antibacterial effect on Gram-negative periopathogens P. 
gingivalis and A. actinomycetemcomitans. The effect of CAP on other microorganisms asso-
ciated with periodontal disease [8] was not analyzed. Within the limitations of this review 
both periopathogens tend to be more susceptible to plasma treatment than the Gram-pos-
itive species. A higher susceptibility of Gram-negative organisms compared to Gram-pos-
itives is consistent with recent reports on non-oral species [86,87]. Yang et al. used ambient 
air as working gas. They showed a higher RF when compared with pure argon- [57] or 
pure helium-driven devices [59]. P. gingivalis was the only obligate anaerobic pathogen in 
the studies included and therefore maybe more sensitive to an elevated amount of ROS 
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induced by plasma, although P. gingivalis developed various strategies to resist oxidative 
stress [88]. Bacterial decontamination is crucial in periodontal and peri-implant therapy. 
The macro- and micro-retentive surface of dental implants is challenging to decontami-
nate. Duske et al. treated subgingival biofilm on sand-blasted and etched titanium discs. 
The SEM images showed that only a combined treatment with a titanium brush and CAP 
resulted in an adequate decontamination [89]. In the combination of air abrasion and CAP, 
CAP did not result in additional effect. In this study, air abrasion by itself resulted in com-
plete biofilm elimination. These tests were performed with an optimal access to the treated 
surface [90]. The activity of different decontamination methods in correlation to the defect 
angulation was further investigated in vitro. The authors showed for all instruments a 
decrease in decontamination depending on the steepness of the defect and no instrument 
achieved complete decontamination in steep defects [91]. Therefore, in a clinical setting, 
an adjunctive antiseptic together with a mechanical decontamination might be beneficial 
as shown in the literature [92]. CAP application may be a promising alternative to the 
current adjunctives. Additional application of CAP resulted in significant higher peri-im-
plant bone level and less inflammation compared to conventional treatment with plastic 
curettes in a ligature-induced peri-implant disease model in beagle dogs 3 months after 
the treatment. Furthermore, levels of P. gingivalis and Tannerella forsythia were signifi-
cantly decreased compared to the control [93]. In the only RCT published, patients were 
treated with adjunctive CAP and showed significant more attachment level gain in severe 
periodontal pockets and a reduced load of periopathogens compared to conventional 
treatment 3 months after therapy [94]. 
The antifungal effect of CAP on C. albicans was investigated in 14 studies, 13 on plain 
surfaces, and 1 in an endodontic model [65]. In accordance with the findings from the 
bacterial experiments, the reduction increased with in a time-dependent manner. Adding 
oxygen had an advantageous effect when using a DBD brush device [70], equivalent to 
the experiments done by Chen et al. [43], but also when using a jet device [73]. The reduc-
tion values in the included studies seemed to be lower than for bacterial species. This may 
be to a higher resistance of the aerobe yeasts to CAP-generated ROS [95]. Biofilm matura-
tion resulted in significant lower reductions [61,67]. 
Üreyen et al. demonstrated a RF of 3.1 log10, when sampling the bacteria with paper 
points after treatment with He/O2 plasma for 5 min. Additionally, they separated the roots 
in thirds, enlarged the canals with burs and recovered the bacteria from the gained dentin 
chips. The values for the coronal, middle and apical third were 3.2 log10, below detection 
level and 3.4 log10, respectively. This shows that the antibacterial effect can be substanti-
ated over the total length of the root canal [50]. E. faecalis is capable of penetrating the 
radial dentin tubuli up to 1000 µm [7] and may reinfect the filled root canal system after 
the primary treatment. It is a predominant pathogen in secondary endodontic infections 
due to its increased resistance against antiseptics [96]. Herbst et al. additionally analyzed 
the penetration depth effect of plasma. The RF was 3.4, 2.1, and 1.4 log10 for the perpen-
dicular dentin sections of 0–300 µm, 300–500 µm, and 500–800 µm, respectively [37]. For 
NaOCl, penetration depths of approximately 100–300 µm in maximum—when acti-
vated—are described in the literature [97–100]. Herbst et al. showed a higher RF for CHX 
2% compared to CAP in the 500–800 µm layer [37]. However, there were also contrary 
reports in regard to the standard irrigants used for endodontic treatment. CAP showed a 
similar [47] or even slightly better reduction on E. faecalis biofilms compared to CHX 2% 
[37,39], and a similar [38] or lower RF compared to NaOCl [35,48,50]. 
When treating a C. albicans biofilm, CAP showed a better antifungal effect compared 
to CHX 2% and NaOCl in a 6 and 12 min application time [65]. Against a multi-species, 
ex-vivo biofilm NaOCl was far more effective than CAP resulting in a reduction of 4.5 
log10 compared to 1.0 log10, respectively. The authors argue that even when inserting the 
plasma needle up to 15 mm into the root canal the plasma effluent is unable to interact 
over a longer distance [48]. Contrary findings were made by Du et al. showing no signifi-
cant difference in the reduction between straight and complex canal anatomies even when 
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inserting plasma nozzle only into the canal orifice [47]. Another interesting aspect of 
plasma application is the reduction of the surface tension [101]. An additional advanta-
geous effect on the irrigants’ disinfecting capability [65,102] and an improved adhesion of 
the restorative material, especially after NaOCl rinsing [77,103], makes CAP a promising 
extension to the established endodontic treatment protocols. In terms of oral candidiasis, 
BALB/c mice were infected with C. albicans and treated with CAP 5 days consecutively. 
Four minutes of treatment appeared ideal for adequate reduction and no damage of the 
superficial epithelium [71]. 
An assessment tool was designed to evaluate the reproducibility of the study proto-
cols. The quality of the studies ranged from 32–92%. Less than half of the studies (23 of 
55) had a quality score of 69% or higher. In nine studies the protocol was described so 
insufficiently that the quality score was under 50%. When authors fail to give relevant 
parameters, the experiments can hardly be repeated and compared. A limitation of this 
article is that due to the heterogeneous results by reason of device parameters and exper-
imental settings a meta-analysis could not be performed. To access appropriate publica-
tions referring to our study question we performed a database search and only included 
research articles. Generally, studies with a high effect of a new treatment option may be 
published in peer-reviewed journals more often than studies showing a small impact of a 
treatment. Some results of the studies included in our review were not significantly dif-
ferent to the control, therefore an overestimated effect of CAP due to a publication bias is 
rather improbable. 
5. Conclusions 
The available evidence from in-vitro studies suggests that CAP is a promising tool in 
combating dental biofilms. Significant reductions can be achieved in a feasible treatment 
time, although the current data showed a broad range of values. Underlying mechanisms 
and specific plasma microbe interactions are not fully understood yet and discussed con-
troversially in the literature. Additional studies are needed to enlighten the correlation of 
power and oxygen admixture with regards to the type of device. Furthermore, brush de-
vices igniting plasma in ambient air seem to be auspicious because no gas tanks are nec-
essary and therefore the clinical implementation of CAP might be easier. To compare the 
activity of different devices, the experimental set-up needs to be standardized to reduce 
variations in outcome determining factors like specimen preparation, inoculum size, 
growth duration of the biofilm, and treatment times. Most studies analyze the antimicro-
bial effect on single-species biofilms. Multi-species biofilms are more challenging and clin-
ically more relevant. More studies using predetermined biofilm compositions need to be 
done. Finally, animal and clinical studies are required to confirm the results found in these 
in-vitro experiments. Possible indications in cariology, endodontology, periodontology, 
and implantology are conceivable. 
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